You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Debio 0123

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,

Not yet recruiting
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
  • Astrocytoma, Grade III
  • Debio 0123
  • +2 more
  • San Antonio, Texas
  • +1 more
Mar 9, 2023

Advanced Solid Tumors Trial in Netherlands, Spain (Debio 0123, Carboplatin)

Recruiting
  • Advanced Solid Tumors
  • Groningen, Netherlands
  • +3 more
Jan 27, 2023

Small Cell Lung Cancer Recurrent Trial in Madrid, Pamplona, Valencia (Debio 0123, Etoposide, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Recurrent
  • Debio 0123
  • +2 more
  • Madrid, Spain
  • +3 more
Apr 3, 2023

Advanced Solid Tumors Trial in Switzerland, United States (Debio 0123)

Recruiting
  • Advanced Solid Tumors
  • Debio 0123
  • Grand Rapids, Michigan
  • +3 more
Jan 27, 2023

Central Precocious Puberty Trial (Debio 4326)

Not yet recruiting
  • Central Precocious Puberty
  • Debio 4326
  • (no location specified)
Nov 8, 2023

Acromegaly, GEP-NET Trial in Worldwide (Debio 4126, Sandostatin LAR, Somatuline ATG)

Recruiting
  • Acromegaly
  • GEP-NET
  • Debio 4126
  • +2 more
  • Copenaghen, Denmark
  • +34 more
Jan 27, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in France, Switzerland (Cisplatin, Radiotherapy, Debio 1143)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Lorient, Bp 2233, France
  • +18 more
Jun 22, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Xevinapant (Debio 1143), Cisplatin, Intensity Modulation

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Xevinapant (Debio 1143)
  • +3 more
  • Gilbert, Arizona
  • +280 more
Aug 22, 2022

NSCLC, Tumors Trial in Canada, Poland, Romania (Debio 1143, Avelumab)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Neoplasms
  • Edmonton, Alberta, Canada
  • +8 more
May 30, 2022

Solid Tumor Trial in Worldwide (Debio 1347)

Terminated
  • Solid Tumor
  • Debio 1347
  • Scottsdale, Arizona
  • +104 more
Mar 30, 2022

Head Neck Cancer Trial in Worldwide (Xevinapant (Debio 1143), IMRT, Placebo)

Recruiting
  • Head and Neck Cancer
  • Xevinapant (Debio 1143)
  • +2 more
  • Birmingham, Alabama
  • +198 more
Nov 2, 2022

Adenocarcinoma of the Pancreas, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Lyon (Pembrolizumab,

Active, not recruiting
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Lyon, France
    Centre Léon Bérard
Mar 17, 2022

DLBCL, B-cell Non-Hodgkin's Lymphoma Trial in Worldwide (Debio 1562, Rituximab)

Completed
  • Diffuse Large B-Cell Lymphoma
  • B-cell Non-Hodgkin's Lymphoma
  • Birmingham, Alabama
  • +38 more
Jan 5, 2022

Solid Tumours Trial in Worldwide (Debio1347 (CH5183284))

Terminated
  • Solid Tumours
  • Debio1347 (CH5183284)
  • Boston, Massachusetts
  • +7 more
Sep 8, 2020

Bacterial Infections Trial in United States (Debio 1450 IV, Debio 1450 Oral, Linezolid)

Completed
Has Results
  • Bacterial Infections
  • Debio 1450 IV
  • +5 more
  • Anaheim, California
  • +21 more
Oct 24, 2019

Cancer, Solid Tumors, Lymphoma Trial in Ann Arbor, Rochester, Durham (Debio 1143 (AT-406))

Completed
  • Cancer
  • +3 more
  • Debio 1143 (AT-406)
  • Ann Arbor, Michigan
  • +2 more
Dec 26, 2018

Esophageal Cancer Trial in Dijon (Conformal 3D Radiotherapy with " ENI "-type prophylactic irradiation of the lymph node, Boost,

Completed
  • Esophageal Cancer
  • Conformal 3D Radiotherapy with " ENI "-type prophylactic irradiation of the lymph node
  • +2 more
  • Dijon, France
    Centre Georges François Leclerc
Jan 24, 2020

Healthy Participants Trial in Leeds (Debio 1450, Itraconazole)

Completed
  • Healthy Participants
  • Leeds, United Kingdom
    Covance Clinical Research Unit Ltd.
Oct 17, 2017

Bone Diseases, Infectious Trial in La Mesa, Butte (Debio 1450)

Completed
  • Bone Diseases, Infectious
  • Debio 1450
  • La Mesa, California
  • +1 more
Oct 17, 2017

Diabetes, Healthy Trial in Neuss (NNC 0123-0000-0338, , insulin glargine)

Completed
  • Diabetes
  • Healthy
  • NNC 0123-0000-0338
  • +2 more
  • Neuss, Germany
    Novo Nordisk Investigational Site
Feb 28, 2017

Solid Tumors Trial in France (Part A: Debio 1143, Paclitaxel, Carboplatin)

Terminated
  • Solid Tumors
  • Part A: Debio 1143
  • +3 more
  • Dijon, France
  • +3 more
Mar 23, 2016

Healthy Trial in Leeds ([14C-pos 1]-Debio 1450 BES Solution, [14C-pos 25]-Debio 1450 BES Solution)

Completed
  • Healthy
  • [14C-pos 1]-Debio 1450 BES Solution
  • [14C-pos 25]-Debio 1450 BES Solution
  • Leeds, United Kingdom
    Covance Clinical Research Unit (CRU) Ltd.
Jan 14, 2016

Chronic Hepatitis C Trial in United States (Debio 025, Peg-IFNa2a, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C
  • Debio 025
  • +2 more
  • la Jolla, California
  • +6 more
Feb 12, 2016

Chronic Hepatitis C Trial in Worldwide (Debio 025, Peg-IFNa2a, Ribavirin)

Completed
  • Chronic Hepatitis C
  • Debio 025
  • +3 more
  • Brussels, Belgium
  • +39 more
Feb 12, 2016

Tenofovir and Resistance Surveillance in Asian-American Adult

Completed
  • Chronic Hepatitis B
    • LA, California
    • +4 more
    Mar 14, 2016